Clinical trial
COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients: a Large Study in the Amsterdam MS Cohort
NCT04498286 is registered in ClinicalTrials.gov with Zoé van Kempen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COVID-19 and SARS-CoV-2 Antibodies in Multiple Sclerosis Patients: a Large Study in the Amsterdam MS Cohort
- Lead sponsor
- Zoé van Kempen
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 8, 2020
- Completion date
- October 31, 2021
- Enrollment
- 546 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.